PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) saw a large increase in short interest in May. As of May 29th, there was short interest totaling 101,221 shares, an increase of 102.8% from the May 14th total of 49,921 shares. Based on an average daily volume of 20,570 shares, the short-interest ratio is presently 4.9 days.
PureTech Health Stock Performance
OTCMKTS:PTCHF remained flat at $1.70 on Monday. The stock’s fifty day moving average is $1.73 and its 200-day moving average is $1.70. PureTech Health has a one year low of $1.55 and a one year high of $1.92.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
See Also
- Five stocks we like better than PureTech Health
- Summer Is Coming–But There’s No End in Sight for This Crypto Winter
- Oil Could Dip, But These 3 Energy Stocks Still Look Built to Win
- What’s Behind the Social Media Controversy Surrounding IonQ?
- 3 Long-Duration Treasury ETFs to Watch if Rates Fall
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
